How to Reconstitute 9-Me-BC

Powder Handling: The Foundation of Safe Preparation

9-Me-BC arrives as a powder and requires no "reconstitution" in the traditional sense—it does not need to be mixed with water or reconstituted solution like peptides (e.g., CJC-1295, GHRP-2) do. Instead, preparation involves careful powder handling, accurate dosing, and safe administration. The primary challenge is protecting the compound from light degradation while measuring and preparing accurate doses. Unlike peptides, which are hydrophilic and require aqueous solutions, 9-Me-BC is a small lipophilic molecule that can be handled as dry powder or dissolved in organic solvents (ethanol, propylene glycol) if preparation as a solution is desired.

When your 9-Me-BC powder arrives, immediately verify the packaging is light-protective (ideally amber glass or opaque container). If it arrives in clear plastic or exposed to light, transfer it to amber glass immediately. Handle the bottle with minimal light exposure; work at dusk or under dim red light when possible. Do not open the container in bright daylight or direct sunlight. Silica gel desiccant packets included in the package help maintain low humidity—do not discard them; ensure they are included if you transfer the powder to new storage containers.

Volumetric Dosing Solution Preparation

Preparing a volumetric solution allows precise, repeatable dosing without handling powder multiple times. A standard volumetric solution involves dissolving 9-Me-BC in ethanol or propylene glycol at a known concentration, allowing you to measure doses by volume. The advantages are substantial: you prepare once, dose multiple times with minimal light exposure, and achieve consistent dosing accuracy.

To prepare a solution at 10 mg/mL: Measure your total amount of 9-Me-BC powder (e.g., 500 mg) using a calibrated scale. Work under dim lighting. Transfer the powder to a clean, dry amber glass bottle (20–30 mL size). Add your chosen solvent: pharmaceutical-grade ethanol or propylene glycol. For 500 mg of powder at 10 mg/mL final concentration, add 50 mL of solvent. Seal the bottle immediately to prevent evaporation and light exposure. Shake vigorously for 30–60 seconds to dissolve the powder completely. If powder remains visible after 1 minute of shaking, the compound may be poorly soluble; allow it to sit for 5–10 minutes and shake again. Once fully dissolved, your solution is stable for months in cool, dark storage.

Before each use, shake the bottle well to ensure even distribution of 9-Me-BC (it may settle slightly over time). Draw your desired dose (e.g., 1 mL for 10 mg) using a syringe, dropper, or volumetric dropper bottle. Administer sublingually by placing under the tongue for 1–2 minutes, or swallow if preferring oral administration. If using ethanol as the solvent, the liquid will taste strongly bitter and may cause mouth/throat irritation; some users dilute the solution 1:1 with water before administration to reduce this.

Capsule Filling and Encapsulation Process

Encapsulating 9-Me-BC into vegetable capsules (size 00, approximately 750 mg capacity) provides another preparation method. Capsules offer convenience, improved stability (the capsule shell protects from light and moisture), and ease of storage compared to loose powder. The tradeoff is slower absorption and slightly lower bioavailability compared to sublingual dosing, as the capsule must dissolve in the stomach before the compound is absorbed.

Manual capsule filling: Measure your desired dose of powder (e.g., 20 mg) using a precision scale and place it in a weighing boat. Separate a size 00 vegetable capsule into its two halves. Using a small funnel or spoon, carefully transfer the powder into the larger capsule half. Tap gently to settle the powder. Carefully slide the smaller half over the larger half to seal the capsule. For a cleaner seal, some users prefer capsule-filling machines (manual capsule machines cost $15–40 online and dramatically improve speed and consistency). Alternatively, use a capsule size 000 (larger, ~1000 mg capacity) if you want to fit a larger dose (30 mg) into a single capsule.

Once filled, store capsules in amber glass bottles with silica desiccant to maintain low humidity and protect from light. Capsules are stable for months in cool, dark storage. When ready to dose, swallow 1–2 capsules with water on an empty or relatively empty stomach. Expect onset of effects in 3–6 hours (oral absorption is slower than sublingual), and effects may be 10–20% less pronounced than sublingual dosing of the same amount.

Light Protection During Preparation and Dosing

Photodegradation is the primary threat to 9-Me-BC during preparation. UV light and blue light rapidly degrade the compound into unknown photoproducts, some of which may be mutagenic. The compound is most vulnerable when powder is exposed during measuring, transferring, and preparing for administration. Minimizing light exposure during these steps is critical for safety and efficacy.

Practical light-protection strategies: Work during evening or night hours, or use dim room lighting (low-wattage incandescent bulbs are safer than LED or fluorescent, which emit more blue light). Better yet, use a red light headlamp or red LED light source; red light (wavelength >600 nm) does not degrade 9-Me-BC and allows you to work while seeing clearly. Some users work under a red lamp or in a bathroom with only red light. If you must work in daylight, use the fastest technique possible: measure your dose in <30 seconds, return the powder to the amber glass bottle immediately, and minimize time the powder is exposed. Do not leave measured powder sitting on a scale or in open air.

For solution preparation: Dissolve the compound in the solvent quickly and seal immediately. For capsule filling: Complete the capsule closure in <60 seconds after transferring powder. Every second of light exposure increases degradation risk. After preparation, store all 9-Me-BC (powder, solution, or capsules) in the dark. Do not store in bathrooms, kitchens, or other bright areas; use a bedroom closet, cabinet, or opaque box in a cool location.

Contamination Prevention and Sterility Concerns

Unlike peptide solutions, which are aqueous and can support bacterial or fungal growth, 9-Me-BC solutions (in ethanol or propylene glycol) are inherently antimicrobial due to the solvent's preservative properties. However, contamination is still possible if the compound is exposed to contaminated water, non-sterile equipment, or improper handling. While 9-Me-BC is not injected (eliminating the sterility concern inherent in injectable peptides), oral and sublingual routes still require basic hygiene.

Basic contamination prevention: Use clean, dry equipment when preparing solutions or filling capsules. Wash hands before handling. If preparing a solution, use a clean glass bottle; do not reuse bottles that previously contained other substances without thorough cleaning and drying. Use pharmaceutical-grade solvents (ethanol or propylene glycol from reputable suppliers), not rubbing alcohol or other impure ethanol, which may contain toxic additives. When measuring powder with a scale, use clean weighing boats or papers; do not reuse contaminated materials. Once prepared, solutions and capsules should be stored in sealed containers away from dust, insects, and moisture.

Stability, Storage Duration, and Environmental Factors

9-Me-BC powder and solutions are stable under proper storage conditions for extended periods. Powder stored in cool, dark, dry conditions (15–25°C, in amber glass, with desiccant) remains stable for 1–2 years. Solutions prepared with ethanol or propylene glycol are similarly stable for 1–2 years in amber glass, sealed bottles in a cool, dark location. The primary degradation driver is light; heat and moisture are secondary factors but still problematic if storage conditions are poor.

Exposure scenarios affecting stability: Room light (fluorescent or LED), 6 hours/day = noticeable degradation over 2–3 weeks. Direct sunlight, 30 minutes = significant degradation. High heat (>30°C), prolonged = slow degradation. High humidity, prolonged = potential moisture absorption and degradation. Storage in a cool, dark, dry closet (15–20°C, minimal light, with desiccant) = minimal degradation over 12–24 months.

Signs of degradation: Powder that appears darker (browning or discoloration), develops unusual odor, or becomes clumpy (moisture absorption). Solutions that become cloudy, discolored, or develop sediment. Any of these signs indicate degradation and the compound should be discarded. Do not attempt to use degraded 9-Me-BC; degradation products are chemically unknown and potentially harmful.

Troubleshooting Common Preparation Issues

Compound won't dissolve in ethanol: This suggests either insufficient ethanol volume relative to powder weight or suboptimal temperature. 9-Me-BC is lipophilic and should dissolve readily in ethanol at room temperature. If it won't dissolve, increase the ethanol volume (ratio target: 20 mg powder to 2 mL ethanol = 10 mg/mL concentration) or gently warm the solution to 30–40°C with occasional stirring. If the compound still won't dissolve completely, the powder may be contaminated or degraded—discard and obtain fresh material. Attempting to use a suspension (undissolved powder in liquid) results in inaccurate dosing.

Measuring powder accurately on a cheap scale: Precision matters for safety. Cheap scales (accuracy ±0.1 g) are insufficient for 9-Me-BC dosing (typical doses are 15–30 mg). Investment in a precision scale accurate to ±0.001 g (milligram precision) is essential. Budget options include Amazon scales for $30–60 that reliably measure 1–100 mg accurately. Never attempt to "eye-ball" or estimate 9-Me-BC doses; measurement error of just a few milligrams can meaningfully affect efficacy and side effect risk. Solutions (measured by volume, e.g., "5 mL of 10 mg/mL solution = 50 mg") are more forgiving of measurement error than powder.

Sublingual solution burns or tastes terrible: Pure ethanol is caustic and unpleasant sublingual. Some users add a flavoring agent (a few drops of liquid stevia or honey) to improve palatability, but ethanol will still produce a burning sensation. Propylene glycol is slightly less caustic. Alternative: Prepare capsules instead of a sublingual solution. The trade-off is slower onset (3–6 hours vs. 30–90 minutes), but capsules eliminate the unpleasant sublingual experience. Most users who initially prefer sublingual for speed eventually switch to capsules for convenience.

Trusted Research-Grade Sources

Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).

Frequently Asked Questions